Assignee
GENCURIX INC
KR·7 granted patents·7 pending applications·3 citations·filing 2013–2024
Top patents by PatentIndex Score
14 records- 0183US10655187B2Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereofGENCURIX INC·Filed 2018·Granted May 19, 2020·3 cites·3 claims
- 0268US2024352537A1Composition for diagnosing prostate cancer by using cpg methylation changes in specific genes, and use thereofGENCURIX INC·Filed 2024·Application pending·0 cites
- 0356US2023084248A1Composition using cpg methylation changes in specific genes to diagnose bladder cancer, and use thereofGENCURIX INC·Filed 2021·Application pending·0 cites
- 0455US10428386B2Gene for predicting the prognosis for early-stage breast cancer, and a method for predicting the prognosis for early-stage breast cancer by using the sameGENCURIX INC·Filed 2016·Granted Oct 1, 2019·0 cites·3 claims
- 0555US2023132750A1Composition for diagnosing colorectal cancer, rectal cancer, or colorectal adenoma using cpg methylation change of glrb gene, and use thereofGENCURIX INC·Filed 2021·Application pending·0 cites
- 0655US2023383356A1Composition for diagnosing colorectal cancer, rectal cancer or colorectal adenoma by using cpg methylation change of linc01798 gene, and use thereofGENCURIX INC·Filed 2021·Application pending·0 cites
- 0750US2024110244A1Composition for diagnosing liver cancer by using cpg methylation changes in specific genes, and use thereofGENCURIX INC·Filed 2020·Application pending·0 cites
- 0850US2013344482A1Gene for predicting the prognosis for early-stage breast cancer, and a method for predicting the prognosis for early-stage breast cancer by using the sameGENCURIX INC·Filed 2013·Application pending·0 cites
- 0947US11840733B2Method for predicting prognosis of breast cancer patientGENCURIX INC·Filed 2017·Granted Dec 12, 2023·0 cites·5 claims
- 1046US10718030B2Methods for predicting effectiveness of chemotherapy for a breast cancer patientGENCURIX INC·Filed 2018·Granted Jul 21, 2020·0 cites·6 claims
- 1145US11970732B2Method for determining nucleic acid quality of biological sampleGENCURIX INC·Filed 2018·Granted Apr 30, 2024·0 cites·9 claims
- 1245US11220716B2Methods for predicting the prognosis of breast cancer patientGENCURIX INC·Filed 2018·Granted Jan 11, 2022·0 cites·8 claims
- 1342US11261482B2Composition for detecting epidermal cell growth factor receptor gene mutation, and kit comprising sameGENCURIX INC·Filed 2017·Granted Mar 1, 2022·0 cites·13 claims
- 1434US2016102359A1Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereofGENCURIX INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENCURIX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →